# 2025年11月2日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 间接量热法揭示ICU患者中与肌肉萎缩和能量亏空风险增加相关的高代谢状态

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41174811](https://pubmed.ncbi.nlm.nih.gov/41174811)
**期刊：** Critical care (London, England)
**PMID：** 41174811
**DOI：** 10.1186/s13054-025-05695-y

### 第一部分 原文与翻译

**英文原标题：** Indirect calorimetry identifies hypermetabolism associated with muscle wasting and increased risk of energy deficit in ICU patients.

**英文摘要原文：**
BACKGROUND & AIMS: Muscle mass loss is a major contributor to morbidity and mortality in Intensive Care Unit (ICU) patients, but the role of metabolic state - particularly energy expenditure - in this process remains unclear. This study investigates the association between metabolic status and muscle mass loss in critically ill adults using indirect calorimetry and CT imaging assessed muscle quantification.

METHODS: In this observational study, adult ICU patients with at least two indirect calorimetry measurements and matched abdominal CT scans were included. Resting energy expenditure (REE) was measured by indirect calorimetry, and muscle mass was quantified as the cross-sectional area (CSA) of the posterior muscle group at the L3 vertebral level. Statistical analyses included regression modeling and group comparisons.

RESULTS: The observational study included 88 patients (n = 88), all of whom underwent at least two calorimetric measurements with corresponding CT scans, and 43 patients (n = 43) had at least three assessments. Persistently elevated normalized energy expenditure per kilogram of body weight (nREE) was independently associated with greater muscle loss. Patients classified as hypermetabolic by nREE experienced significantly more muscle wasting than those with lower metabolic activity. Hypermetabolism was associated with increased inflammatory markers, while sedation or agitation (RAAS) and higher level of consciousness (GCS) were not related to metabolic state.

CONCLUSIONS: Persistent hypermetabolism in ICU patients is independently associated with accelerated muscle mass loss. Early identification of hypermetabolic patients using indirect calorimetry may enable targeted nutritional interventions to reduce muscle mass wasting and improve clinical outcomes.

**中文摘要译文：**
背景与目的：肌肉量减少是重症监护室（ICU）患者发病和死亡的主要原因之一，但代谢状态——特别是能量消耗——在这一过程中的作用仍不清楚。本研究旨在利用间接量热法和CT影像评估的肌肉量化技术，探讨危重症成年患者的代谢状态与肌肉量减少之间的关联。

方法：这项观察性研究纳入了至少有两次间接量热法测量和相匹配的腹部CT扫描的成年ICU患者。通过间接量热法测量静息能量消耗（REE），并通过L3椎体水平后方肌群的横截面积（CSA）来量化肌肉质量。统计分析包括回归建模和组间比较。

结果：该观察性研究共纳入88名患者（n=88），所有患者均接受了至少两次量热测量及相应的CT扫描，其中43名患者（n=43）接受了至少三次评估。持续升高的单位体重标准化能量消耗（nREE）与更严重的肌肉减少独立相关。根据nREE被分类为高代谢状态的患者，其肌肉萎缩程度显著高于代谢活动较低的患者。高代谢状态与炎症标志物水平升高相关，而镇静或躁动程度（RAAS）及意识水平（GCS）与代谢状态无关。

结论：ICU患者的持续性高代谢状态与肌肉量的加速减少独立相关。通过间接量热法早期识别高代谢患者，可能有助于实施针对性的营养干预，以减少肌肉萎缩并改善临床结局。

### 第二部分 AI 大师评价

该研究通过前瞻性地结合间接量热法与CT影像分析，精准探讨了ICU患者代谢状态与肌肉流失之间的关系，具有重要的临床创新性。其核心发现——持续性高代谢是肌肉加速萎缩的独立危险因素——为临床实践提供了明确的警示。该结论强调了动态监测能量代谢对于危重病人营养管理的关键价值，为早期识别高风险患者并实施个性化营养干预策略提供了有力证据，对改善患者预后具有直接的指导意义。

---

## 2. 室间隔曲率比：一种预测血压正常的急性肺栓塞患者临床恶化的新型影像标志物

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41174707](https://pubmed.ncbi.nlm.nih.gov/41174707)
**期刊：** Critical care (London, England)
**PMID：** 41174707
**DOI：** 10.1186/s13054-025-05708-w

### 第一部分 原文与翻译

**英文原标题：** Ventricular septum curvature ratio: a novel imaging marker to predict clinical deterioration in normotensive acute pulmonary embolism.

**英文摘要原文：**
BACKGROUND: Identifying high-probability deterioration individuals at the time of admission remains a challenge in normotensive patients with acute pulmonary embolism (PE). Ventricular septum (VS) deviation, as observed on computed tomography pulmonary angiography (CTPA), has been associated with poor prognosis in acute PE patients. However, the quantitative relationship between the VS curvature ratio and clinical deterioration in normotensive acute PE patients has not been fully explored. This study aimed to investigate the role of the VS curvature ratio derived from CTPA as an image marker for deterioration in normotensive acute PE patients.

METHODS: This prospective multicenter cohort study enrolled normotensive patients with acute PE across five centers in China between January 2021 and June 2024. The VS and left ventricle (LV) free-wall curvature radii were measured using CTPA, and the VS curvature ratio was calculated and categorized. The endpoint was the occurrence of clinical deterioration event within 30 days after admission. The relationship between the VS curvature ratio and deterioration was analyzed using hierarchical logistic regression. The efficacy of identifying deterioration was assessed using the area under the receiver operating characteristic curve (AUC).

RESULTS: Of 3,310 patients, 272 (8.2%) experienced deterioration. In 3,030 patients from three centres, VS were categorized into four groups: VS bowing to the RV with its curvature ratio as < 1.60, 1.60-<1.90, ≥ 1.90, respectively; and the fourth group with VS straight or bowing to the LV. Using a VS curvature ratio < 1.60 as the reference, patients with higher VS curvature ratios had an increased risk of deterioration (odds ratio: 22.94 for ≥ 1.90 and 22.95 for VS straight & bowing to the LV, both p < 0.05). The VS curvature ratio demonstrated good discrimination for deterioration, with an AUC of 0.83 in the three local centers and 0.84 in the two non-local centers (280 patients).

CONCLUSIONS: The VS curvature ratio, derived from CTPA images, is a promising image marker for predicting deterioration in normotensive acute PE patients. This study highlights the potential clinical impact of VS curvature ratio to identify normotensive PE patients at increased risk of deterioration and to adjust management strategies accordingly.

CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT05098769, October 16,2021, retrospectively registered.

**中文摘要译文：**
背景：对于血压正常的急性肺栓塞（PE）患者，在入院时识别出具有高可能性发生临床恶化的个体仍然是一个挑战。在计算机断层扫描肺动脉血管造影（CTPA）上观察到的室间隔（VS）偏曲已被证实与急性PE患者的不良预后相关。然而，VS曲率比与血压正常的急性PE患者临床恶化之间的定量关系尚未被充分探讨。本研究旨在探讨源自CTPA的VS曲率比作为预测血压正常的急性PE患者临床恶化的影像标志物的作用。

方法：这项前瞻性多中心队列研究于2021年1月至2024年6月期间，在中国五个中心招募了血压正常的急性PE患者。研究使用CTPA测量VS和左心室（LV）游离壁的曲率半径，并计算与分类VS曲率比。研究终点是入院后30天内发生临床恶化事件。采用分层逻辑回归分析VS曲率比与临床恶化之间的关系。通过受试者工作特征曲线下面积（AUC）评估其识别临床恶化的效能。

结果：在3310名患者中，有272名（8.2%）经历了临床恶化。在来自三个中心的3030名患者中，VS被分为四组：VS向右心室（RV）膨出，其曲率比分别为<1.60、1.60-<1.90、≥1.90；第四组为VS平直或向左心室（LV）膨出。以VS曲率比<1.60为参照，具有更高VS曲率比的患者发生临床恶化的风险增加（比值比：≥1.90组为22.94，VS平直及向LV膨出组为22.95，两者的p值均<0.05）。VS曲率比在识别临床恶化方面表现出良好的区分能力，在三个本地中心的AUC为0.83，在两个非本地中心（280名患者）的AUC为0.84。

结论：源自CTPA图像的VS曲率比是预测血压正常的急性PE患者发生临床恶化的一个有前景的影像标志物。本研究强调了VS曲率比在识别具有更高恶化风险的正常血压PE患者并相应调整管理策略方面的潜在临床影响力。

临床试验注册：ClinicalTrials.gov 标识符：NCT05098769，2021年10月16日，回顾性注册。

### 第二部分 AI 大师评价

该研究聚焦于血压正常的急性肺栓塞（PE）患者这一临床风险分层难点，创新性地提出并验证了室间隔（VS）曲率比作为预测临床恶化的新型影像标志物。通过一项大规模、前瞻性多中心队列研究，本研究证实了基于CTPA测量的VS曲率比与患者30天内临床恶化风险显著相关，且具有良好的预测效能（AUC > 0.8）。这项发现的临床价值巨大，它提供了一个客观、量化且易于获取的工具，有助于早期识别出高危的“正常血压”PE患者，从而为及时的干预和治疗策略调整提供了关键依据。

---

## 3. 非奈利酮对比螺内酯在慢性肾脏病合并2型糖尿病患者中的应用：一项目标试验模拟研究

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41173939](https://pubmed.ncbi.nlm.nih.gov/41173939)
**期刊：** Nature communications
**PMID：** 41173939
**DOI：** 10.1038/s41467-025-64640-3

### 第一部分 原文与翻译

**英文原标题：** Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation.

**英文摘要原文：**
The comparative effectiveness of finerenone and spironolactone in chronic kidney disease (CKD) with type 2 diabetes (T2D) remains unclear. Here we show, using a target trial emulation on global real-world data from TriNetX, outcomes among 2268 propensity score-matched adults with CKD (eGFR 15-60 mL/min/1.73 m²) and T2D who initiated finerenone or spironolactone between July 2021 and September 2024. Over a median follow-up of 1.3 years, finerenone is associated with lower risks of major adverse cardiovascular events (adjust hazard ratio [aHR], 0.74; 95% CI, 0.58-0.94), major adverse kidney events (aHR, 0.47; 95% CI, 0.33-0.67), all-cause mortality (aHR, 0.31; 95% CI, 0.21-0.45), and hyperkalemia (17.2% vs. 26.4%; P < 0.001) compared with spironolactone. These findings suggest potential benefits of finerenone over spironolactone in reducing mortality and cardiorenal risk among patients with CKD and T2D.

**中文摘要译文：**
在慢性肾脏病（CKD）合并2型糖尿病（T2D）患者中，非奈利酮与螺内酯的相对有效性尚不明确。本研究利用来自TriNetX全球真实世界数据的目标试验模拟方法，对2268名在2021年7月至2024年9月期间开始使用非奈利酮或螺内酯，且患有CKD（eGFR 15-60 mL/min/1.73 m²）和T2D的倾向性评分匹配成年患者的临床结局进行了分析。在中位随访1.3年期间，与螺内酯相比，非奈利酮与更低的主要不良心血管事件风险（调整后风险比[aHR], 0.74; 95% CI, 0.58-0.94）、主要不良肾脏事件风险（aHR, 0.47; 95% CI, 0.33-0.67）、全因死亡率风险（aHR, 0.31; 95% CI, 0.21-0.45）以及更低的高钾血症发生率（17.2% vs. 26.4%; P < 0.001）相关。这些发现表明，在降低CKD合并T2D患者的死亡率和心肾风险方面，非奈利酮可能优于螺内酯。

### 第二部分 AI 大师评价

本研究采用新颖的目标试验模拟方法，基于大规模真实世界数据，旨在解决一个关键的临床问题：在慢性肾脏病合并2型糖尿病患者中，新型药物非奈利酮相较于传统药物螺内酯的有效性与安全性如何。研究的关键发现指出，非奈利酮在降低心肾复合终点、全因死亡率及高钾血症风险方面均显著优于螺内酯。这项研究的价值在于，它为缺乏直接头对头随机对照试验（RCT）的领域提供了高质量的循证医学证据，其结果可能深刻影响临床实践指南，并推动对该高危患者群体的治疗策略优化。

---

## 4. 脓毒性休克中亚甲蓝的使用：一项回顾性队列研究

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41171046](https://pubmed.ncbi.nlm.nih.gov/41171046)
**期刊：** Critical care medicine
**PMID：** 41171046
**DOI：** 10.1097/CCM.0000000000006934

### 第一部分 原文与翻译

**英文原标题：** Methylene Blue Administration in Septic Shock: A Retrospective Cohort Study.

**英文摘要原文：**
OBJECTIVES: To describe the epidemiology of methylene blue (MB) use in septic shock and explore the association between MB dose and hospital outcomes.

DESIGN: Retrospective cohort study.

SETTING: United States.

PATIENTS: Eight hundred fifty-nine thousand eight hundred sixty-eight adult (≥ 18 yr) patients from 1100 centers with a diagnosis of septic shock (sepsis with vasopressor administration), discharged from Premier Healthcare Database hospitals in the United States from 2008 to 2021.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We included patients who received MB at any point during hospitalization (to describe utilization), then separately focused on those who received MB within the first 3 hospital days (to examine association of dose with outcomes). The primary outcome was hospital mortality. We used mixed-effects multivariable regression models to evaluate the MB use and the association between MB dose (modeled as a five-knot restricted cubic spline) and outcomes. Among patients with septic shock, 4082 patients (0.5%) from 663 hospitals received at least one dose of MB. Patients receiving MB tended to be younger and received major surgery. Hospitals in which MB was administered were larger urban teaching hospitals. After multivariable adjustment, use of MB was lower in 2016-2020 than in 2008. Of 2507 patients (61.4%) who received MB within the first 3 days of hospitalization, 375 (15.0%) died in hospital. Our spline analysis suggests a nonlinear association between MB dosing and outcomes among patients receiving MB early in their hospitalization.

CONCLUSIONS: Use of MB in septic shock is rare in the United States, but with substantial inter-hospital variability and decreased use over time through 2020. Randomized evidence is required to evaluate the efficacy and safety of MB.

**中文摘要译文：**
目的：描述脓毒性休克中亚甲蓝（MB）使用的流行病学特征，并探讨亚甲蓝剂量与住院结局之间的关联。

设计：回顾性队列研究。

地点：美国。

患者：纳入2008年至2021年间，从美国Premier医疗保健数据库中的1100家中心出院的859,868名诊断为脓毒性休克（脓毒症并使用血管升压药）的成年（≥18岁）患者。

干预措施：无。

测量指标与主要结果：我们纳入了在住院期间任何时间点接受过亚甲蓝治疗的患者（以描述其使用情况），然后单独重点分析了在住院前3天内接受亚甲蓝治疗的患者（以检验剂量与结局的关联）。主要结局为院内死亡率。我们采用混合效应多变量回归模型评估亚甲蓝的使用情况以及亚甲蓝剂量（建模为五结限制性立方样条）与结局之间的关联。在脓毒性休克患者中，来自663家医院的4082名患者（0.5%）接受了至少一剂亚甲蓝治疗。接受亚甲蓝治疗的患者往往更年轻，并接受过大型手术。使用亚甲蓝的医院多为大型城市教学医院。经多变量校正后，2016-2020年亚甲蓝的使用率低于2008年。在住院前3天内接受亚甲蓝治疗的2507名患者（61.4%）中，有375名（15.0%）在院内死亡。我们的样条分析表明，在住院早期接受亚甲蓝治疗的患者中，亚甲蓝剂量与结局之间存在非线性关联。

结论：在美国，亚甲蓝在脓毒性休克中的使用很少见，但存在显著的院间差异，并且截至2020年，其使用率随时间推移而下降。需要通过随机对照试验证据来评估亚甲蓝的有效性和安全性。

### 第二部分 AI 大师评价

本研究基于一项大规模回顾性队列分析，首次描绘了亚甲蓝在美国脓毒性休克治疗中的应用现状。研究发现，尽管亚甲蓝作为一种潜在的治疗选择，其临床应用极为罕见（0.5%），且存在显著的院间差异并随时间推移呈下降趋势。该研究的创新之处在于利用真实世界大数据揭示了亚甲蓝使用的流行病学全貌，并提示了剂量与结局间可能存在的非线性关系，虽未证实其疗效，但为未来开展相关随机对照试验（RCT）提供了重要的现实依据和方向。

---

## 5. 吸引急诊医学住院医师投身外科重症监护：一项对有志于重症领域的急诊受训者开展的全国性调查的启示

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41171038](https://pubmed.ncbi.nlm.nih.gov/41171038)
**期刊：** Critical care medicine
**PMID：** 41171038
**DOI：** 10.1097/CCM.0000000000006935

### 第一部分 原文与翻译

**英文原标题：** Attracting Emergency Medicine-Trained Residents to Surgical Critical Care: The Implications From a Nationwide Survey of Emergency Medicine Trainees Interested in Critical Care.

**英文摘要原文：**
OBJECTIVES: Emergency medicine (EM) surgical critical care (SCC) trained physicians offer many advantages to SCC. However, several fields of critical care (CC) compete with SCC for EM intensivists. We hypothesized that there are definable and potentially modifiable factors related to the pathway selection.

DESIGN: Cross-sectional survey.

SETTING: Four national EM societies.

SUBJECTS: EM trainees (residents and fellows).

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: The primary outcome included the top factors leading to pathway selection. Secondary outcomes included influential factors for entering CC and individual components of a CC fellowship that interest the EM trainee. One hundred eleven EM trainees responded-42 fellows and 69 residents. Median age was 32 (interquartile range, 30-35). Sixty-seven were matched (fellows + matched residents). Intended fields of practice: 49 anesthesiology CC (26 matched), 58 medicine CC (29 matched), two neurology CC (1 matched), six resuscitation (one matched), 15 SCC (eight matched), and five non-CC (two matched). Top factors for pathway selection included exposure to specialty units, geography and specialty multidisciplinary teams (p < 0.05). Ease of board certification was not influential. Only 28% of trainees had exposure to EM-SCC fellowships at their residency institution and only 42% had exposure to surgical intensivists during training. However, 41% envisioned practicing in a surgical ICU. Before application season, 8.2% did not have exposure to a surgical ICU/trauma ICU/trauma service that managed their ICU patients in contrast to the 3.2% of applicants not having medical ICU exposure. The highest-ranking factor for entering CC was intellectual appeal over job opportunities and lifestyle (p < 0.05). When assessing components of individual fellowship programs, CC knowledge, the institutional value of EM/critical care medicine, and extracorporeal membrane oxygenation exposure ranked highly.

CONCLUSIONS: Given the complexity of the modifiable barriers for EM-SCC matriculation, a multifaceted approach is necessary to increase matriculants. Interventions specific to the specialty are required at professional societal, institutional, and training program levels.

**中文摘要译文：**
目的：接受急诊医学（EM）和外科重症监护（SCC）培训的医师能为SCC领域带来诸多优势。然而，多个重症监护（CC）领域与SCC竞争急诊重症医师。我们假设，存在与职业路径选择相关的、可明确且可能改变的因素。

设计：横断面调查。

地点：四个全国性急诊医学学会。

对象：急诊医学受训者（住院医师和专科医师）。

干预措施：无。

测量与主要结果：主要结局包括导致路径选择的首要因素。次要结局包括进入CC领域的影响因素以及CC专科培训项目中吸引EM受训者的具体组成部分。共111名EM受训者做出回应，其中包括42名专科医师和69名住院医师。中位年龄为32岁（四分位距为30-35岁）。67人已匹配（专科医师+已匹配的住院医师）。预期的执业领域包括：49人选择麻醉CC（26人已匹配），58人选择内科CC（29人已匹配），2人选择神经科CC（1人已匹配），6人选择复苏（1人已匹配），15人选择SCC（8人已匹配），5人选择非CC领域（2人已匹配）。影响路径选择的首要因素包括专科病房的接触机会、地理位置以及专科多学科团队（p < 0.05）。获得专科医师资格认证的难易程度并无显著影响。仅28%的受训者在其住院医师培训机构接触过EM-SCC专科培训项目，仅42%在培训期间接触过外科重症医师。然而，41%的人设想在外科ICU执业。在申请季之前，8.2%的受训者未曾接触过管理其ICU患者的外科ICU/创伤ICU/创伤服务，相比之下，仅3.2%的申请者未接触过内科ICU。进入CC领域的最高排名因素是智力上的吸引力，其重要性超过了工作机会和生活方式（p < 0.05）。在评估各个专科培训项目的组成部分时，CC知识、机构对EM/重症监护医学的重视程度以及体外膜肺氧合（ECMO）的接触机会排名靠前。

结论：鉴于EM背景医师进入SCC领域的障碍复杂且可改变，需要采取多方面的方法来增加申请人数。需要在专业学会、机构和培训项目等层面采取针对该专业的干预措施。

### 第二部分 AI 大师评价

该研究通过一项全国性横断面调查，精准探究了影响急诊医学（EM）受训者选择外科重症监护（SCC）作为职业发展路径的关键因素。研究发现，尽管许多EM受训者对在外科ICU工作抱有兴趣，但由于培训期间接触SCC项目和导师的机会有限，实际选择该路径的人数不多。本研究的价值在于，它系统性地量化了这一特定亚专科人才管道中的障碍与驱动力，为解决SCC领域的人才短缺问题提供了实证依据。其结论具有重要的实践指导意义，指出通过在专业学会、培训机构等层面增加相关轮转和接触机会，是吸引更多急诊医师投身外科重症领域的有效策略。

---

## 6. 这名患儿需要ICU吗？——论儿科重症监护病房与普通病房中需要机械通气患儿的护理

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41171037](https://pubmed.ncbi.nlm.nih.gov/41171037)
**期刊：** Critical care medicine
**PMID：** 41171037
**DOI：** 10.1097/CCM.0000000000006927

### 第一部分 原文与翻译

**英文原标题：** Does This Child Need the ICU? The Care of Children Requiring Mechanical Ventilation in Pediatric Critical Care Units and General Care Wards.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

由于本文献无可用摘要，仅从标题推断，其核心目的在于探讨需要机械通气的患儿收治于儿科重症监护室（PICU）或普通病房的决策标准和护理策略。该研究可能旨在通过分析不同监护环境下患儿的临床结局，为临床医生提供决策依据。此议题具有重要的临床实践价值，有助于优化医疗资源分配，并确保患儿在最适宜的环境下获得安全有效的治疗。然而，缺乏摘要内容使得我们无法深入了解其具体的研究方法、关键数据和结论。

---

## 7. 头孢吡肟与碳青霉烯类药物治疗产AmpC酶深部感染的比较：一项倾向性加权回顾性队列研究

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41170947](https://pubmed.ncbi.nlm.nih.gov/41170947)
**期刊：** Antimicrobial agents and chemotherapy
**PMID：** 41170947
**DOI：** 10.1128/aac.00928-25

### 第一部分 原文与翻译

**英文原标题：** Comparison between cefepime and carbapenem therapy for deep-seated AmpC-producing  infections: a propensity-weighted retrospective cohort study.

**英文摘要原文：**
Deep-seated infections caused by AmpC-producing  (AmpC-E) pose challenges due to high bacterial burdens, altered pharmacokinetics, and the inoculum effect. While cefepime and carbapenems are used for bloodstream infections, their comparative effectiveness for deep-seated AmpC-E infections remains uncertain. This retrospective cohort study (2010-2023) evaluated adult inpatients with deep-seated infections caused by AmpC-E ( complex, , or ). Patients received cefepime or a carbapenem within 48 hours of index culture for ≥72 hours. Definitive therapy (high-dose cefepime or a carbapenem) was administered for ≥70% of the treatment course. The primary outcome was clinical failure, defined as (i) all-cause mortality within 30 days of index culture or (ii) infection recurrence within 30 days after completion of definitive therapy. Pooled logistic regression with inverse probability treatment weighting (IPTW) and time-varying covariates (year of therapy start, time to source control) estimated predictors of failure. Of 480 patients (cefepime  = 243, carbapenem  = 237),  complex accounted for 63.9% of infections. Unadjusted 30-day clinical failure rates were similar (14.8% for cefepime vs 11.4% for carbapenem;  = 0.267). After IPTW, carbapenem therapy had lower odds of clinical failure (adjusted odds ratio [aOR], 0.44; 95% confidence interval [CI], 0.29-0.83;  = 0.033). Intensive care unit (ICU) admission increased failure odds (aOR, 2.39; 95% CI, 1.70-3.35;  < 0.001); source control reduced them (aOR, 0.52; 95% CI, 0.40-0.68;  = 0.029). Carbapenem therapy is associated with lower adjusted odds of clinical failure than cefepime in deep-seated AmpC-E infections. ICU admission was independently associated with increased odds of clinical failure, while source control was associated with reduced odds of failure.

**中文摘要译文：**
由产AmpC酶的肠杆菌科细菌（AmpC-E）引起的深部感染因其菌量高、药代动力学改变和接种物效应而构成挑战。虽然头孢吡肟和碳青霉烯类药物用于血流感染，但它们对深部AmpC-E感染的比较有效性仍不确定。这项回顾性队列研究（2010-2023年）评估了因AmpC-E（复合物、或）引起的深部感染的成年住院患者。患者在指标培养后的48小时内接受头孢吡肟或碳青霉烯类药物治疗≥72小时。确定性治疗（高剂量头孢吡肟或碳青霉烯类药物）的给药时间占总疗程的≥70%。主要结局是临床失败，定义为(i)指标培养后30天内的全因死亡率或(ii)确定性治疗完成后30天内的感染复发。采用合并logistic回归结合逆概率治疗加权（IPTW）和时变协变量（治疗开始年份、感染源控制时间）来估计失败的预测因素。在480名患者中（头孢吡肟组=243人，碳青霉烯组=237人），复合物感染占63.9%。未经调整的30天临床失败率相似（头孢吡肟组为14.8%，碳青霉烯组为11.4%；P = 0.267）。经IPTW校正后，碳青霉烯类治疗的临床失败几率更低（调整后比值比[aOR]为0.44；95%置信区间[CI]为0.29-0.83；P = 0.033）。入住重症监护室（ICU）会增加失败几率（aOR为2.39；95% CI为1.70-3.35；P < 0.001）；而感染源控制则降低失败几率（aOR为0.52；95% CI为0.40-0.68；P = 0.029）。在深部AmpC-E感染中，与头孢吡肟相比，碳青霉烯类治疗与更低的调整后临床失败几率相关。ICU入住是临床失败几率增加的独立相关因素，而感染源控制则与失败几率降低相关。

### 第二部分 AI 大师评价

本研究通过一项大规模、倾向性加权的回顾性队列研究，旨在解决临床上一个重要的争议：对于产AmpC酶细菌引起的深部感染，头孢吡肟与碳青霉烯类药物的疗效差异。研究方法严谨，利用逆概率治疗加权（IPTW）有效校正了混杂因素，增强了结论的可靠性。其核心发现——在调整后，碳青霉烯类药物的临床失败风险显著低于头孢吡肟，为这类重症感染的抗生素选择提供了关键的循证医学证据，对指导临床实践中权衡“节省碳青霉烯”策略与患者预后具有重要价值。

---

## 8. 应用二氯乙酸盐刺激丙酮酸脱氢酶复合物或可改善脓毒症心功能障碍

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41170803](https://pubmed.ncbi.nlm.nih.gov/41170803)
**期刊：** Shock (Augusta, Ga.)
**PMID：** 41170803
**DOI：** 10.1097/SHK.0000000000002642

### 第一部分 原文与翻译

**英文原标题：** Pyruvate Dehydrogenase Complex Stimulation with Dichloroacetate May Improve Septic Cardiac Dysfunction.

**英文摘要原文：**
BACKGROUND: Cardiomyopathy is a common complication of sepsis that contributes to increased morbidity and mortality. However, the molecular mechanisms underlying septic cardiomyopathy are poorly understood. Dichloroacetate (DCA) improves mitochondrial respiration and survival in a mouse model of sepsis by inhibiting pyruvate dehydrogenase kinase which inactivates pyruvate dehydrogenase (PDH) through phosphorylation of its subunits. In this study, we explore the role of DCA in septic cardiac dysfunction using a murine sepsis model.

METHODS: Cecal ligation and puncture (CLP) was performed in mice to investigate molecular and echocardiographic response to sepsis. DCA was administered to test the effects of PDH activation on cardiac performance during early and late sepsis and myocardial metabolic substrate production. Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry was used to reveal spatial alterations in metabolism.

RESULTS: CLP significantly increased phosphorylation of the PDH E1α subunit (PDH inactivation), and DCA treatment reduced PDH E1α phosphorylation (PDH activation) to baseline without affecting total PDH E1α levels. Administration of DCA at the time of CLP improved cardiac preload and stroke volume without affecting cardiac contractility at 12 h after CLP. However, there was a significant increase in cardiac contractility at 30 h after DCA administration independent of cardiac loading conditions. This improved cardiac function after DCA administration was associated with a trend toward decreased production of metabolic intermediates such as ketogenic amino acids, succinate, and palmitoyl carnitine. Imaging mass spectrometry revealed an increase in itaconate expression upon CLP that was mitigated by DCA administration.

CONCULSIONS: Our findings revealed that sepsis decreased PDH activity in cardiac tissue. Rebalancing PDH activity with DCA improved cardiac performance after CLP. While imaging mass spectrometry identified changes in itaconate concentration and enabled detection of tricarboxylic acid cycle metabolites, further investigation is necessary to determine whether DCA is an effective therapeutic agent for septic cardiomyopathy.

**中文摘要译文：**
背景：心肌病是脓毒症的一种常见并发症，它会导致发病率和死亡率的增加。然而，脓毒症心肌病的分子机制尚不明确。二氯乙酸盐（DCA）通过抑制丙酮酸脱氢酶激酶来改善脓毒症小鼠模型的线粒体呼吸和存活率，该激酶通过磷酸化丙酮酸脱氢酶（PDH）亚基使其失活。本研究旨在利用鼠类脓毒症模型，探讨DCA在脓毒症心功能障碍中的作用。

方法：对小鼠实施盲肠结扎穿孔术（CLP），以研究其对脓毒症的分子和超声心动图反应。给予DCA以测试PDH激活在脓毒症早期和晚期对心脏性能及心肌代谢底物生成的影响。采用基质辅助激光解吸/电离（MALDI）成像质谱技术揭示代谢的空间变化。

结果：CLP显著增加了PDH E1α亚基的磷酸化水平（PDH失活），而DCA治疗则将PDH E1α的磷酸化水平降低至基线水平（PDH激活），且不影响总PDH E1α的水平。在CLP时给予DCA，可在术后12小时改善心脏前负荷和每搏输出量，而不影响心肌收缩力。然而，在给予DCA后30小时，心肌收缩力出现显著增加，且该作用独立于心脏负荷条件。DCA给药后心脏功能的改善与生酮氨基酸、琥珀酸盐和棕榈酰肉碱等代谢中间产物生成的减少趋势相关。成像质谱分析显示，CLP导致衣康酸盐表达增加，而DCA给药可减轻这一变化。

结论：我们的研究结果揭示，脓毒症会降低心脏组织中的PDH活性。应用DCA重新平衡PDH活性可改善CLP后的心脏性能。尽管成像质谱技术识别了衣康酸盐浓度的变化并实现了对三羧酸循环代谢物的检测，但仍需进一步研究以确定DCA是否是治疗脓毒症心肌病的有效药物。

### 第二部分 AI 大师评价

本研究旨在探讨通过药物二氯乙酸盐（DCA）激活丙酮酸脱氢酶（PDH）复合物，是否能够改善脓毒症引发的心功能障碍。研究团队采用经典的小鼠盲肠结扎穿孔（CLP）脓毒症模型，结合超声心动图与先进的成像质谱技术，系统评估了DCA的干预效果。关键发现证实，脓毒症确实会抑制心脏的PDH活性，而DCA能有效逆转此过程，从而在不同阶段改善心脏的前负荷、搏出量及收缩力，并调节关键代谢物（如衣康酸盐）的水平。这项研究不仅揭示了脓毒症心肌病的一个重要代谢调控靶点，也为DCA作为潜在治疗药物提供了有力的临床前证据，具有较高的科研与转化价值。

---

## 9. 非结核分枝杆菌肺病的新遗传位点及体重指数的潜在保护作用

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40938630](https://pubmed.ncbi.nlm.nih.gov/40938630)
**期刊：** American journal of respiratory and critical care medicine
**PMID：** 40938630
**DOI：** 10.1164/rccm.202406-1253OC

### 第一部分 原文与翻译

**英文原标题：** Novel Genetic Loci for Nontuberculous Mycobacterial Pulmonary Disease and Potential Protective Effect of Body Mass Index.

**英文摘要原文：**
Although nontuberculous mycobacteria (NTM) are widespread, only some individuals develop NTM pulmonary disease (NTM-PD), suggesting the involvement of host factors. To identify the genomic structure of NTM-PD and determine whether a definitive association exists between NTM-PD and nine risk factors. We performed genome-wide association studies in two independent Korean cohorts involving 1,949 patients with NTM-PD and 2,955 healthy participants. Significantly associated genetic variants were validated in Japanese (1,137 cases, 1,546 controls) and European (243 cases, 570 controls) cohorts, respectively. Genes associated with lead variants were identified and their roles in NTM-PD were supported by single-cell transcriptome datasets. Genetic correlations and Mendelian randomization between NTM-PD and nine risk factors were examined. We identified two novel loci and replicated a locus associated with NTM-PD: rs60084385 (odds ratio [OR], 1.34; 95% confidence interval [CI], 1.21-1.48;  = 6.97 × 10), rs1479595 (OR, 1.40; 95% CI, 1.27-1.55;  = 7.08 × 10), and rs194792 (OR, 1.70; 95% CI, 1.50-1.93;  = 1.39 × 10). These associations were replicated in the independent cohorts. The three loci were significantly associated with expression of , (phosphodiesterase 8B), and (protein kinase C β), respectively, whose involvement in the pathogenesis of NTM-PD was further validated. Among the risk factors, only body mass index demonstrated both a significant genetic correlation with NTM-PD (, -0.57; false discovery rate, 1.33 × 10) and a potential causal relationship (OR, 0.38; 95% CI, 0.24-0.59; false discovery rate, 8.55 × 10). Our study identified three genetic loci associated with NTM-PD and a negative association of body mass index with NTM-PD.

**中文摘要译文：**
尽管非结核分枝杆菌（NTM）广泛存在，但只有部分个体发展为NTM肺病（NTM-PD），这表明宿主因素参与其中。本研究旨在鉴定NTM-PD的基因组结构，并确定NTM-PD与九种风险因素之间是否存在明确的关联。我们在两个独立的韩国队列中进行了全基因组关联研究，共涉及1949名NTM-PD患者和2955名健康参与者。显著相关的遗传变异分别在日本（1137例病例，1546例对照）和欧洲（243例病例，570例对照）队列中得到了验证。我们识别了与主要变异相关的基因，并通过单细胞转录组数据集支持了它们在NTM-PD中的作用。我们还检验了NTM-PD与九种风险因素之间的遗传相关性和孟德尔随机化关系。我们发现了两个与NTM-PD相关的新位点，并重复验证了一个位点：rs60084385（比值比[OR], 1.34; 95%置信区间[CI], 1.21-1.48; P = 6.97 × 10⁻¹¹）、rs1479595（OR, 1.40; 95% CI, 1.27-1.55; P = 7.08 × 10⁻¹¹）和rs194792（OR, 1.70; 95% CI, 1.50-1.93; P = 1.39 × 10⁻²¹）。这些关联在独立队列中得到了重复验证。这三个位点分别与CLN3、PDE8B（磷酸二酯酶8B）和PRKCB（蛋白激酶C β）的表达显著相关，其参与NTM-PD发病机制的作用得到了进一步证实。在这些风险因素中，只有体重指数与NTM-PD同时表现出显著的遗传相关性（rg, -0.57; 错误发现率, 1.33 × 10⁻⁴）和潜在的因果关系（OR, 0.38; 95% CI, 0.24-0.59; 错误发现率, 8.55 × 10⁻⁵）。我们的研究确定了三个与NTM-PD相关的遗传位点，以及体重指数与NTM-PD的负向关联。

### 第二部分 AI 大师评价

本研究通过一项大规模、多族裔的全基因组关联研究（GWAS），旨在揭示非结核分枝杆菌肺病（NTM-PD）的遗传易感位点，并探究其与体重指数（BMI）等风险因素的因果关系。研究成功鉴定出两个新的易感基因位点并验证了一个已知位点，并通过孟德尔随机化分析揭示了较高BMI对NTM-PD可能具有因果性的保护作用。该研究的创新性在于其严谨的多队列验证设计和对因果关系的探索，其发现不仅加深了对NTM-PD发病机制的理解，也为临床风险评估和预防策略提供了重要的遗传学证据。

---

## 10. 辅助通气期间的呼吸力学与死亡率

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40788692](https://pubmed.ncbi.nlm.nih.gov/40788692)
**期刊：** American journal of respiratory and critical care medicine
**PMID：** 40788692
**DOI：** 10.1164/rccm.202506-1377ED

### 第一部分 原文与翻译

**英文原标题：** Respiratory Mechanics and Mortality during Assisted Ventilation.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

根据该文献的标题和文章类型（社论），推测其核心内容并非一项原创性研究，而是一篇专家评述。该文旨在探讨在接受辅助通气的患者中，呼吸力学参数与死亡率之间的内在联系。作者可能通过评述该领域的最新研究，强调了监测和优化呼吸力学（如驱动压、顺应性等）对于改善危重患者预后的临床重要性。此类社论对于临床医生理解前沿进展、指导通气策略具有重要的参考价值，并为未来的研究方向提供了深刻启示。

---

## 11. 非编码DNA变异提高了原发性纤毛运动障碍的基因诊断率。

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40758541](https://pubmed.ncbi.nlm.nih.gov/40758541)
**期刊：** American journal of respiratory and critical care medicine
**PMID：** 40758541
**DOI：** 10.1164/rccm.202501-0186OC

### 第一部分 原文与翻译

**英文原标题：** Noncoding DNA Variants Increase the Genetic Diagnostic Yield in Primary Ciliary Dyskinesia.

**英文摘要原文：**
Primary ciliary dyskinesia (PCD) is a rare respiratory disorder of motile cilia caused by pathogenic variants in >50 known genes. Genetic testing routinely examines the coding regions of these genes, and biallelic pathogenic variants are reported in as many as 70% of patients. Many patients remain with an incomplete or no genetic diagnosis.  To retrospectively analyze the diagnostic yield in 496 patients referred for genetic testing and the increase in yield by investigating pathogenic DNA variants in the noncoding regions of PCD genes in 42 patients with an incomplete genetic diagnosis.  End-to-end next-generation gene sequencing including coding and noncoding regions of 17 PCD genes was performed, following routine genetic diagnosis of a panel of more than 46 genes. Intronic variants were prioritized for pathogenicity using  tools to predict splice effects that were subsequently confirmed in RNA extracted from nasal epithelium.  232 of 496 patients (46.8%) had a complete genetic diagnosis of PCD after stringent variant assessment during routine genetic testing. Eighty-six patients (17.3%) had an incomplete genetic diagnosis, 42 of whom had end-to-end gene sequencing. Novel, potentially pathogenic, noncoding variants were identified in 16 of 42 patients (38.1%). Three recurrent deep-intronic variants were found.  Diagnostic yield for PCD is increased by end-to-end gene sequencing. Noncoding variants that affect splicing are recurrent and are an important source of pathogenic genomic variation in patients with PCD. This work illustrates the potential clinical utility of end-to-end gene or genome sequencing for PCD.

**中文摘要译文：**
原发性纤毛运动障碍（PCD）是一种由超过50个已知基因的致病性变异引起的罕见活动纤毛呼吸系统疾病。基因检测常规检查这些基因的编码区，在高达70%的患者中可报告双等位基因致病性变异。许多患者仍未获得完整的基因诊断或根本没有基因诊断。本研究旨在回顾性分析496名接受基因检测患者的诊断率，并通过研究42名基因诊断不完整患者PCD基因非编码区的致病性DNA变异，来评估诊断率的提升情况。在对超过46个基因进行常规基因panel诊断之后，我们对17个PCD基因的编码和非编码区进行了端到端的下一代基因测序。使用预测剪接效应的工具对内含子变异的致病性进行优先排序，随后通过从鼻上皮细胞提取的RNA进行验证。在常规基因检测的严格变异评估后，496名患者中有232名（46.8%）获得了PCD的完整基因诊断。86名患者（17.3%）的基因诊断不完整，其中42名接受了端到端的基因测序。在这42名患者中，有16名（38.1%）发现了新的、潜在致病性的非编码变异。发现了三种复发性的深内含子变异。端到端的基因测序提高了PCD的诊断率。影响剪接的非编码变异是复发性的，并且是PCD患者致病性基因组变异的重要来源。这项工作阐明了端到端的基因或基因组测序在PCD诊断中的潜在临床应用价值。

### 第二部分 AI 大师评价

本研究旨在解决原发性纤毛运动障碍（PCD）中部分患者基因诊断不明确的难题。研究者通过对诊断不完整的患者进行包含非编码区的端到端基因测序，成功在超过三分之一的此类患者中发现了新的致病性非编码变异。这一关键发现不仅显著提升了PCD的基因诊断率，更凸显了将非编码区分析纳入遗传病诊断流程的临床价值与必要性，为未来通过全基因组测序等手段攻克罕见病诊断瓶颈提供了有力证据。

---

## 12. 对Bardsley观点的回应：当前吸烟状态与慢性阻塞性肺疾病药物治疗反应的关系尚无定论。

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40680215](https://pubmed.ncbi.nlm.nih.gov/40680215)
**期刊：** American journal of respiratory and critical care medicine
**PMID：** 40680215
**DOI：** 10.1164/rccm.202505-1076LE

### 第一部分 原文与翻译

**英文原标题：** Reply to Bardsley : Current Smoking and Pharmacological Treatment Responses in Chronic Obstructive Pulmonary Disease: Not Clear-Cut.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

本文是一篇致编辑的回信，旨在回应Bardsley的观点，探讨了当前吸烟状态对慢性阻塞性肺疾病（COPD）患者药物治疗反应的复杂影响。作者通过标题明确指出，两者间的关系并非一目了然，暗示现有研究结论可能过于简化。虽然该文章形式决定了其不包含原创性实验数据，但它通过学术思辨，促进了科学界对于如何优化吸烟COPD患者治疗策略的深入讨论，并可能指出了未来需要进一步研究的方向。

---

## 13. 无创通气期间的反向触发：一项新发现

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40680149](https://pubmed.ncbi.nlm.nih.gov/40680149)
**期刊：** American journal of respiratory and critical care medicine
**PMID：** 40680149
**DOI：** 10.1164/rccm.202412-2542IM

### 第一部分 原文与翻译

**英文原标题：** Reverse Triggering during Noninvasive Ventilation: A Novel Observation.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

本文首次报道了在接受无创通气（NIV）的患者中观察到反向触发这一特殊的呼吸机-患者异步现象。反向触发此前主要在有创机械通气中被认识，此项新发现在无创领域具有开创性意义。该研究提示临床医生需警惕NIV期间也可能发生此类复杂的呼吸机-患者相互作用，对于优化通气策略、改善患者舒适度和治疗效果至关重要。尽管作为初步观察，其发生率和临床影响尚待进一步研究，但该发现为理解NIV下的呼吸生理学开辟了新的视角。

---

## 14. 对Girard的回应：肺部超声弹性成像作为个性化机械通气的新工具

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40669083](https://pubmed.ncbi.nlm.nih.gov/40669083)
**期刊：** American journal of respiratory and critical care medicine
**PMID：** 40669083
**DOI：** 10.1164/rccm.202503-0565LE

### 第一部分 原文与翻译

**英文原标题：** Reply to Girard : Lung Ultrasound Elastography: New Tools to Personalize Mechanical Ventilation.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无摘要。

### 第二部分 AI 大师评价

本文是对Girard评论的回应，聚焦于肺部超声弹性成像作为一种个性化机械通气新工具的潜力。文章可能探讨了该技术在评估肺部力学特性、指导呼吸机参数设置以避免呼吸机相关肺损伤方面的应用前景。尽管这篇回应性文章（Letter to the Editor）没有提供原创性研究数据，但它推动了关于如何利用先进成像技术优化危重患者治疗策略的学术讨论，对临床和科研具有启发意义。

---

## 15. 肺部超声弹性成像：个性化机械通气的新工具。

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40669077](https://pubmed.ncbi.nlm.nih.gov/40669077)
**期刊：** American journal of respiratory and critical care medicine
**PMID：** 40669077
**DOI：** 10.1164/rccm.202502-0406LE

### 第一部分 原文与翻译

**英文原标题：** Lung Ultrasound Elastography: New Tools to Personalize Mechanical Ventilation.

**英文摘要原文：**
No abstract available.

**中文摘要译文：**
无可用摘要。

### 第二部分 AI 大师评价

本文（可能为一篇述评或致编辑信）提出了一个创新性概念，即应用肺部超声弹性成像技术作为一种新工具，以实现个性化的机械通气策略。该技术有望通过无创、床旁评估肺组织机械特性，为临床医生提供实时反馈，从而优化呼吸机参数设置，可能有助于减少呼吸机相关肺损伤。尽管缺乏摘要信息，无法深入了解其具体方法和数据支持，但该标题揭示了一个极具前景的研究方向，对于重症监护领域的精准治疗具有重要的启发价值。

---

## 16. 社区获得性肺炎的血浆蛋白质组：病理生理学、结局及十年风险

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40600965](https://pubmed.ncbi.nlm.nih.gov/40600965)
**期刊：** American journal of respiratory and critical care medicine
**PMID：** 40600965
**DOI：** 10.1164/rccm.202502-0325OC

### 第一部分 原文与翻译

**英文原标题：** The Plasma Proteome in Community-acquired Pneumonia: Pathophysiology, Outcome, and 10-Year Risk.

**英文摘要原文：**
Community-acquired pneumonia (CAP) represents a significant health burden. We aimed to map the plasma proteome in patients with CAP and associate protein abundance with pathophysiology, tissue source, and outcome. We measured the plasma proteome of patients with CAP upon admission to a general ward using Olink technology (derivation cohort). Additional Olink measurements were performed in patients with CAP admitted to the ICU and patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia across care settings (validation cohorts). Of 2,676 proteins analyzed in 93 ward patients with CAP and 21 healthy control subjects, 904 (33.8%) were higher in CAP, 396 (14.8%) lower, and 1,376 (51.4%) not different. More abundant proteins were associated with innate immune and mitosis pathways and mainly originated from lung and cardiac tissue. A total of 131 proteins associated with time to clinical stability (TCS), of which 124 (primarily related to monocyte and macrophage and RNA processing) were connected with a long TCS. Most TCS-associated proteins were differentially abundant in nonsurvivors versus survivors among 88 patients with ICU-CAP (1.4- to 3.5-fold higher) and 305 patients with SARS-CoV-2 pneumonia (1.16- to 1.35-fold lower or 1.14- to 2.65-fold higher; all  < 0.05). In the general population (UK Biobank), 115 of 124 (92.7%) proteins correlated with long TCS were associated with an increased risk of pneumonia during a 10-year follow-up, whereas 6 of 7 (85.7%) proteins correlated with shorter TCS were associated with a lower risk of pneumonia. This now publicly available CAP plasma proteome provides information on pathophysiological mechanisms and tissue involvement and may support development of personalized therapies.

**中文摘要译文：**
社区获得性肺炎（CAP）是一项重大的健康负担。我们旨在绘制CAP患者的血浆蛋白质组图谱，并将蛋白质丰度与病理生理学、组织来源和临床结局相关联。我们使用Olink技术测量了收入普通病房的CAP患者（衍生队列）的血浆蛋白质组。我们还对收入ICU的CAP患者以及在不同医疗环境中接受治疗的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）肺炎患者（验证队列）进行了额外的Olink测量。在对93名普通病房CAP患者和21名健康对照者的2,676种蛋白质进行分析后，发现CAP患者中有904种（33.8%）蛋白质水平较高，396种（14.8%）较低，1,376种（51.4%）无差异。丰度较高的蛋白质与先天免疫和有丝分裂通路相关，且主要来源于肺和心脏组织。共有131种蛋白质与达到临床稳定时间（TCS）相关，其中124种（主要与单核细胞、巨噬细胞及RNA加工有关）与较长的TCS相关。在88名ICU-CAP患者和305名SARS-CoV-2肺炎患者中，大多数与TCS相关的蛋白质在非幸存者与幸存者之间存在差异性丰度（在ICU-CAP患者中高1.4至3.5倍；在SARS-CoV-2肺炎患者中低1.16至1.35倍或高1.14至2.65倍；所有P值均小于0.05）。在普通人群（英国生物银行）中，与长TCS相关的124种蛋白质中有115种（92.7%）与十年随访期内肺炎风险增加相关，而与短TCS相关的7种蛋白质中有6种（85.7%）与肺炎风险降低相关。这项现已公开的CAP血浆蛋白质组数据为揭示病理生理机制和组织受累情况提供了信息，并可能支持个体化疗法的开发。

### 第二部分 AI 大师评价

本研究通过高通量Olink技术，系统描绘了社区获得性肺炎（CAP）患者的血浆蛋白质组图谱，旨在揭示其病理生理机制并识别与临床结局及长期风险相关的蛋白标志物。研究的关键发现不仅在于识别出大量与先天免疫、肺和心脏组织损伤相关的差异蛋白，更创新性地将急性期与临床稳定时间（TCS）相关的蛋白特征与普通人群长达十年的肺炎发病风险建立了联系。这项工作为理解CAP的全身性影响提供了宝贵的分子层面的证据，其公开的数据集对未来开发个体化诊疗策略和预后生物标志物具有重要的科研与临床转化价值。

---

## 17. 低氧性呼吸衰竭患者辅助通气期间驱动压升高与ICU生存率降低相关：ICEBERG研究

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40540619](https://pubmed.ncbi.nlm.nih.gov/40540619)
**期刊：** American journal of respiratory and critical care medicine
**PMID：** 40540619
**DOI：** 10.1164/rccm.202411-2146OC

### 第一部分 原文与翻译

**英文原标题：** Increased Driving Pressure During Assisted Ventilation for Hypoxemic Respiratory Failure Is Associated with Lower ICU Survival: The ICEBERG Study.

**英文摘要原文：**
Driving pressure (ΔP) is a marker of severity and a possible target for lung protection during controlled ventilation, but its value during assisted ventilation is unknown. Inspiratory holds provide an estimate of ΔP that is quasi-static. Expiratory holds provide an estimate of the inspiratory effort, which is useful to estimate the transpulmonary dynamic ΔP.  To assess the correlation between ΔPs measured during assisted ventilation and ICU outcomes.  Multicenter prospective observational study. Patients with acute hypoxemic respiratory failure were enrolled within 48 hours of triggering the ventilator. Respiratory mechanics were measured daily, and the variables of interest were averaged over the first 3 days of partial assistance. ICU outcomes were collected until Day 90.  A total of 298 patients from 16 centers were enrolled. Vt, peak airway pressure, positive end-expiratory pressure, and inspiratory effort during the first 3 days of assisted ventilation did not differ between survivors and nonsurvivors. Quasi-static ΔP and transpulmonary dynamic ΔP were higher in nonsurvivors than in survivors (13 [IQR, 11-14] vs. 11 [9-13] cm HO [ < 0.001]; and 19 [16-23] vs. 16 [13-18] cm HO [ < 0.001], respectively), whereas compliance normalized to predicted body weight was lower (0.65 [0.54-0.84] vs. 0.79 [0.64-0.97] mL/cm HO/kg;  < 0.001). Multivariable analysis confirmed the association with outcomes. During the study days, static ΔP significantly diverged between survivors and nonsurvivors.  During assisted ventilation, ΔP and normalized compliance are associated with ICU outcome, despite some overlap. Although our study does not allow an estimation of whether ΔP is a marker of severity or a cause of lung injury, it highlights the potential value of monitoring and targeting it during spontaneous assisted breathing.

**中文摘要译文：**
驱动压（ΔP）是控制通气期间反映病情严重程度的标志物，也是肺保护策略的潜在目标，但其在辅助通气中的价值尚不明确。吸气末屏气可以提供准静态ΔP的估计值。呼气末屏气可以提供吸气努力的估计值，这对于估算跨肺动态ΔP很有用。本研究旨在评估辅助通气期间测量的ΔP与ICU结局之间的相关性。这是一项多中心前瞻性观察性研究。研究纳入了在触发呼吸机48小时内的急性低氧性呼吸衰竭患者。每日测量呼吸力学参数，并将相关变量在部分辅助通气的前3天内取平均值。收集截至第90天的ICU结局。共纳入来自16个中心的298名患者。在辅助通气的前3天，幸存者与非幸存者之间的潮气量、气道峰压、呼气末正压和吸气努力无显著差异。非幸存者的准静态ΔP和跨肺动态ΔP均高于幸存者（分别为13 [IQR, 11-14] vs. 11 [9-13] cm H₂O [P < 0.001]；以及19 [16-23] vs. 16 [13-18] cm H₂O [P < 0.001]），而根据预测体重校正的顺应性则较低（0.65 [0.54-0.84] vs. 0.79 [0.64-0.97] mL/cm H₂O/kg; P < 0.001）。多变量分析证实了这种与结局的关联。在研究期间，幸存者与非幸存者的静态ΔP呈现出显著的分离趋势。在辅助通气期间，尽管存在一定程度的重叠，ΔP和校正后的顺应性与ICU结局相关。尽管我们的研究无法确定ΔP是病情严重程度的标志物还是肺损伤的原因，但它凸显了在自主辅助呼吸期间监测和靶向调控ΔP的潜在价值。

### 第二部分 AI 大师评价

本项研究（ICEBERG研究）通过一项多中心前瞻性观察研究，创新性地探讨了在存在自主呼吸的辅助通气模式下，驱动压（ΔP）与低氧性呼吸衰竭患者ICU生存率的关系。研究关键发现，较高的准静态ΔP和跨肺动态ΔP与ICU死亡率显著相关，这为在辅助通气阶段监测和干预ΔP提供了重要的临床证据。尽管研究本质无法确定因果关系，但其结果强调了将肺保护性通气策略从完全控制通气延伸至辅助通气阶段的必要性，对重症监护实践具有重要的指导价值。

---

速递结束，祝您工作愉快！